Showing results (1651-1660 of 1,665) with videos related to

Sort By:
Pageof 167
Annals of Emergency Medicine|June 18, 2024
Rapid Acute Coronary Syndrome Evaluation Over One Hour With High-Sensitivity Cardiac Troponin I: A United States-Based Stepped-Wedge, Randomized TrialJoseph Miller, Bernard Cook, Chaun Gandolfo, et al.
BMJ (Clinical Research Ed.)|June 13, 2022
Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling studyKuan Ken Lee, Dimitrios Doudesis, Mohamed Anwar, et al.
Cell|November 5, 2022
Architecture of the outbred brown fat proteome defines regulators of metabolic physiologyHaopeng Xiao, Luiz H M Bozi, Yizhi Sun, et al.
The New England Journal of Medicine|March 2, 2022
High-Sensitivity Troponin I after Cardiac Surgery and 30-Day MortalityP J Devereaux, Andre Lamy, Matthew T V Chan, et al.
The New England Journal of Medicine|June 27, 2019
Application of High-Sensitivity Troponin in Suspected Myocardial InfarctionJohannes T Neumann, Raphael Twerenbold, Francisco Ojeda, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 12, 2019
Global Vascular Guidelines on the Management of Chronic Limb-Threatening IschemiaMichael S Conte, Andrew W Bradbury, Philippe Kolh, et al.
Nature Genetics|May 4, 2010
A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4Terri H Beaty, Jeffrey C Murray, Mary L Marazita, et al.
Plos Medicine|November 16, 2016
Exposure Patterns Driving Ebola Transmission in West Africa: A Retrospective Observational Study, Junerlyn Agua-Agum, Archchun Ariyarajah, et al.
The Lancet. Neurology|March 22, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trialRandall J Bateman, Yan Li, Eric M McDade, et al.
Nature Medicine|June 22, 2021
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseStephen Salloway, Martin Farlow, Eric McDade, et al.
Pageof 167